• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脓毒症的诊断与治疗:德国脓毒症协会及德国跨学科重症与急诊医学学会指南]

[Diagnosis and therapy of sepsis: guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].

作者信息

Reinhart K, Brunkhorst F, Bone H, Gerlach H, Gründling M, Kreymann G, Kujath P, Marggraf G, Mayer K, Meier-Hellmann A, Peckelsen C, Putensen C, Quintel M, Ragaller M, Rossaint R, Stüber F, Weiler N, Welte T, Werdan K

机构信息

Deutsche Sepsis-Gesellschaft e V c/o Universitatsklinikum Jena, Erlanger Allee 101, 07747 Jena.

出版信息

Anaesthesist. 2006 Jun;55 Suppl 1:43-56.

PMID:17051663
Abstract

A recent survey conducted by the publicly funded Competence Network Sepsis (SepNet) reveals that severe sepsis and/or septic shock occurs in 75,000 inhabitants (110 out of 100,000) and sepsis in 79,000 inhabitants (116 out of 100,000) in Germany annually. This illness is responsible for approximately 60,000 deaths and ranges as the third most frequent cause of death after acute myocardial infarction. Direct costs for the intensive care of patients with severe sepsis alone amount to approximately 1.77 billion euros, which means that about 30% of the budget in intensive care is used to treat severe sepsis. However, until now German guidelines for the diagnosis and therapy of severe sepsis did not exist. Therefore, the German Sepsis Society initiated the development of guidelines which are based on international recommendations by the International Sepsis Forum (ISF) and the Surviving Sepsis Campaign (SSC) and take into account the structure and organization of the German health care system. Priority was given to the following guideline topics: a) diagnosis, b) prevention, c) causative therapy, d) supportive therapy, e) adjunctive therapy. The guidelines development process was carefully planned and strictly adhered to the requirements of the Working Group of Scientific Medical Societies (AWMF).

摘要

由公共资助的脓毒症能力网络(SepNet)近期开展的一项调查显示,在德国,每年有7.5万居民(每10万人中有110人)发生严重脓毒症和/或脓毒性休克,7.9万居民(每10万人中有116人)发生脓毒症。这种疾病导致约6万人死亡,是仅次于急性心肌梗死的第三大常见死因。仅严重脓毒症患者的重症监护直接费用就约达17.7亿欧元,这意味着重症监护预算中约30%用于治疗严重脓毒症。然而,到目前为止,德国尚无严重脓毒症的诊断和治疗指南。因此,德国脓毒症协会启动了指南的制定工作,该指南以国际脓毒症论坛(ISF)和拯救脓毒症运动(SSC)的国际建议为基础,并考虑了德国医疗保健系统的结构和组织。以下指南主题被列为优先事项:a)诊断,b)预防,c)病因治疗,d)支持治疗,e)辅助治疗。指南制定过程经过精心规划,并严格遵守科学医学协会工作组(AWMF)的要求。

相似文献

1
[Diagnosis and therapy of sepsis: guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].[脓毒症的诊断与治疗:德国脓毒症协会及德国跨学科重症与急诊医学学会指南]
Anaesthesist. 2006 Jun;55 Suppl 1:43-56.
2
[Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].[脓毒症的诊断与治疗。德国脓毒症协会及德国重症与急诊医学跨学科协会指南]
Internist (Berl). 2006 Apr;47(4):356, 358-60, 362-8, passim. doi: 10.1007/s00108-006-1595-x.
3
[Diagnosis and therapy of sepsis].[脓毒症的诊断与治疗]
Clin Res Cardiol. 2006 Aug;95(8):429-54. doi: 10.1007/s00392-006-0414-7.
4
Practice and perception--a nationwide survey of therapy habits in sepsis.实践与认知——一项关于脓毒症治疗习惯的全国性调查
Crit Care Med. 2008 Oct;36(10):2719-25. doi: 10.1097/CCM.0b013e318186b6f3.
5
[Guidelines of hemodynamic monitor and support in adult patients with severe sepsis and septic shock (draft)].[成人严重脓毒症与脓毒性休克血流动力学监测与支持指南(草案)]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Mar;19(3):129-33.
6
Urosepsis: from the intensive care viewpoint.尿脓毒症:从重症监护角度看
Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S79-84. doi: 10.1016/j.ijantimicag.2007.07.014. Epub 2007 Dec 3.
7
Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.脓毒性休克患儿血流动力学支持的时间和液体敏感性复苏:在发展中国家一家儿科重症监护病房实施美国危重病医学会/儿科高级生命支持指南的障碍
Pediatr Emerg Care. 2008 Dec;24(12):810-5. doi: 10.1097/PEC.0b013e31818e9f3a.
8
[Guidelines for intensive care in cardiac surgery patients: haemodynamic monitoring and cardio-circulatory treatment guidelines of the German Society for Thoracic and Cardiovascular Surgery and the German Society of Anaesthesiology and Intensive Care Medicine].[心脏外科手术患者重症监护指南:德国胸心血管外科学会与德国麻醉学和重症医学学会的血流动力学监测及心肺循环治疗指南]
Thorac Cardiovasc Surg. 2007 Mar;55(2):130-48. doi: 10.1055/s-2007-964939.
9
Advances in the management of sepsis: the randomised controlled trials behind the Surviving Sepsis Campaign recommendations.脓毒症管理的进展:拯救脓毒症运动推荐背后的随机对照试验
Int J Antimicrob Agents. 2006 Feb;27(2):97-101. doi: 10.1016/j.ijantimicag.2005.11.003. Epub 2006 Jan 18.
10
The management of severe sepsis and septic shock.严重脓毒症和脓毒性休克的管理
Infect Dis Clin North Am. 2009 Sep;23(3):485-501. doi: 10.1016/j.idc.2009.04.002.

引用本文的文献

1
The prevalence of sepsis-induced coagulopathy in patients with sepsis - a secondary analysis of two German multicenter randomized controlled trials.脓毒症患者中脓毒症诱导的凝血病的患病率——两项德国多中心随机对照试验的二次分析
Ann Intensive Care. 2023 Jan 12;13(1):3. doi: 10.1186/s13613-022-01093-7.
2
Antimicrobial resistance of bacteraemia in the emergency department of a German university hospital (2013-2018): potential carbapenem-sparing empiric treatment options in light of the new EUCAST recommendations.德国大学医院急诊科的菌血症的抗菌药物耐药性(2013-2018 年):根据新的欧盟药敏试验委员会推荐意见,潜在的可减少碳青霉烯类药物使用的经验性治疗选择。
BMC Infect Dis. 2019 Dec 30;19(1):1091. doi: 10.1186/s12879-019-4721-9.
3
C-Terminal Alpha-1 Antitrypsin Peptide: A New Sepsis Biomarker with Immunomodulatory Function.
C 末端α-1抗胰蛋白酶肽:一种具有免疫调节功能的新型脓毒症生物标志物。
Mediators Inflamm. 2016;2016:6129437. doi: 10.1155/2016/6129437. Epub 2016 Jun 13.
4
Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients.靶向代谢组学用于鉴别危重症患者的系统性炎症性疾病。
J Lipid Res. 2012 Jul;53(7):1369-75. doi: 10.1194/jlr.P023309. Epub 2012 May 11.
5
Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study.危重病肌病发病早期的危重病相关危险因素:一项前瞻性观察研究。
Crit Care. 2010;14(3):R119. doi: 10.1186/cc9074. Epub 2010 Jun 18.
6
The association between body-mass index and patient outcome in septic shock: a retrospective cohort study.肥胖指数与脓毒性休克患者预后的关联:一项回顾性队列研究。
Wien Klin Wochenschr. 2010 Jan;122(1-2):31-6. doi: 10.1007/s00508-009-1241-4.
7
[Erythrocyte transfusion: update of the guidelines "therapy with blood components and plasma derivatives"].[红细胞输血:《血液成分和血浆衍生物治疗指南》更新版]
Anaesthesist. 2009 Nov;58(11):1150-8. doi: 10.1007/s00101-009-1621-1.
8
Cardiac effects of induction agents in the septic rat heart.在脓毒症大鼠心脏中诱导剂的心脏效应。
Crit Care. 2009;13(5):R144. doi: 10.1186/cc8038. Epub 2009 Sep 8.
9
Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation.载脂蛋白 HDL 相关变化与人类脓毒症死亡率相关,并与单核细胞和血小板激活相关。
Intensive Care Med. 2009 Nov;35(11):1877-85. doi: 10.1007/s00134-009-1609-y. Epub 2009 Aug 8.
10
Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients.以羟乙基淀粉(HES)为主的液体疗法和以非HES为主的液体疗法对外科重症监护病房患者肾功能的影响。
Intensive Care Med. 2009 Sep;35(9):1539-47. doi: 10.1007/s00134-009-1509-1. Epub 2009 Jun 17.